Has the time come for predictive computer modeling in CNS drug discovery and development?

CPT: Pharmacometrics and Systems Pharmacology

Volumn 1, Issue 1, 2012, Pages

  Geerts, H ^a,b   Spiros, A ^a   Roberts, P ^a,c   Carr, R ^a  

^a In Silico Biosciences ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIFEPRUNOX; CENTRAL NERVOUS SYSTEM AGENTS; DIMEBON;

COMPUTER MODEL; DRUG TARGETING; HUMAN; MITOCHONDRIAL MEMBRANE; NERVE CELL NETWORK; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE SYSTEM PHARMACOLOGY; REVIEW;

EID: 84875456220     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2012.17     Document Type: Review

References (10)

1. Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3, 711-715 (2004
2. Arrowsmith, J. Trial watch: Phase II failures: 2008-2010. Nat. Rev. Drug Discov. 10, 328- 329 (2011
3. Geerts, H. Of mice and men: Bridging the translational disconnect in CNS drug discovery. CNS Drugs 23, 915-926 (2009
4. Hodgkin, A.L. & Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (Lond.) 117, 500-544 (1952
5. Grasela, T.H. & Slusser, R. Improving productivity with model-based drug development: An enterprise perspective. Clin. Pharmacol. Ther. 88, 263-268 (2010
6. Spiros, A., Roberts, P., & Geerts, H. A Quantitative systems pharmacology computer model for schizophrenia efficacy and extrapyramidal side effects. Drug Dev. Res. 73, 1098-1109 (2012
7. Spiros, A., Carr, R. & Geerts, H. Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse. Neuropsychiatr. Dis. Treat. 6, 589-603 (2010
8. Geerts H., Roberts, P., & Spiros, A. Failure analysis of dimebon using mechanistic disease modeling: lessons for clinical development of new AD therapies. Alzheimer's & Dementia 8 (suppl.311), P1-307 (2012
9. Bouteiller, J.M. et al. Integrated multiscale modeling of the nervous system: Predicting changes in hippocampal network activity by a positive AMPA receptor modulator. IEEE Trans. Biomed. Eng. 58, 3008-3011 (2011
10. Hurko, O. & Ryan, J.L. Translational research in central nervous system drug discovery. NeuroRx 2, 671-682 (2005